The current study is the first report to reveal that non-toxic concentrations of statins markedly potentiate the growth inhibitory effects of either a prodrug (CHR2863) or a direct inhibitor (bestatin) of aminopeptidases in human AML cells. Here, CPQ is linked to acute myeloid leukemia.